These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 16360262)
1. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome. Mitkov M; Pehlivanov B; Terzieva D Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262 [TBL] [Abstract][Full Text] [Related]
2. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome. Mitkov M; Pehlivanov B; Terzieva D Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):209-13. PubMed ID: 15653205 [TBL] [Abstract][Full Text] [Related]
3. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091 [TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765 [TBL] [Abstract][Full Text] [Related]
5. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome. Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894 [TBL] [Abstract][Full Text] [Related]
6. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
7. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907 [TBL] [Abstract][Full Text] [Related]
8. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
9. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome. Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962 [TBL] [Abstract][Full Text] [Related]
10. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome]. Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846 [TBL] [Abstract][Full Text] [Related]
11. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome]. Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
13. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564 [TBL] [Abstract][Full Text] [Related]
14. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J; Zhu Y; Jiang Y; Cao Y Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [TBL] [Abstract][Full Text] [Related]
15. [Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome]. Ma LK; Jin LN; Yu Q; Xu L Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):294-7. PubMed ID: 17673038 [TBL] [Abstract][Full Text] [Related]
16. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Nawrocka J; Starczewski A Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944 [TBL] [Abstract][Full Text] [Related]
17. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome]. Pekhlivanov B; Mitkov M; Kavŭrdzhikova S Akush Ginekol (Sofiia); 2006; 45(6):29-35. PubMed ID: 17168480 [TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome. Kriplani A; Agarwal N J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709 [TBL] [Abstract][Full Text] [Related]
19. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study. Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]